cgp 12177 has been researched along with Insulin Resistance in 2 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marette, A | 1 |
| Mauriège, P | 1 |
| Després, JP | 1 |
| Tulp, OL | 1 |
| Bukowiecki, LJ | 1 |
| Hellström, L | 1 |
| Reynisdottir, S | 1 |
| Langin, D | 1 |
| Rössner, S | 1 |
| Arner, P | 1 |
2 other studies available for cgp 12177 and Insulin Resistance
| Article | Year |
|---|---|
Norepinephrine- and insulin-resistant glucose transport in brown adipocytes from diabetic SHR/N-cp rats.
Topics: Adipose Tissue, Brown; Animals; Biological Transport; Diabetes Mellitus; Drug Resistance; Female; Gl | 1993 |
Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adipocytes; Adrenergic beta-Agonists; Adult; Brimonidine Tar | 1996 |